Newswise — WASHINGTON (Dec. 5, 2023) — The FDA agreed to require important American Academy of Dermatology’s (AAD) recommended changes to the iPLEDGE program that will alleviate administrative burdens ...

March 9, 2006 (San Francisco) — The largest and arguably most complex risk-management program ever undertaken by the US Food and Drug Administration is sparking a commensurate measure of controversy — ...

In December 2021, major changes took effect in the iPLEDGE program, the US Food and Drug Administration (FDA)–required safety program for managing the risks of isotretinoin's teratogenicity and ...

It has been 13 years since the U.S. Food and Drug Administration took a bold step to prevent birth defects caused by the only drug that can cure severe acne. Women were still getting pregnant while ...

Please provide your email address to receive an email when new articles are posted on . iPLEDGE requires participating pharmacies to have an identifying number, which jails and prisons do not have.

Please provide your email address to receive an email when new articles are posted on . Pregnancies, abortions and fetal defects associated with isotretinoin exposure continue to be a problem even ...

If you’ve had a difficult time getting your Accutane in the last few weeks, you’re not alone. A recent month-long outage of the Food and Drug Administration’s iPledge Program kept many prescription ...

(HealthDay)—The iPLEDGE program needs to provide women with information about more contraceptive choices, including reversible contraceptives, according to research published in the April issue of ...

The iPLEDGE program, a strengthened risk management program to educate women about the risk of becoming pregnant while taking isotretinoin (Accutane and its generics), a drug to treat severe ...

WASHINGTON The Food and Drug Administration announced that Covance, the developer of the iPLEDGE risk management program has fully implemented the program revisions approved by the FDA on Oct. 3. The ...